Covered recipient · General Payments record
ALEXANDER KULCZYCKI
Allopathic & Osteopathic Physicians Hospitalist
General Payments · PY2018–2023
$7,047.58
- Reported across 532 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $212.09 | 14 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $44.13 | 3 |
| PFIZER INC. | $31.90 | 2 |
| Esperion Therapeutics, Inc. | $30.57 | 2 |
| Lilly USA, LLC | $29.70 | 2 |
| ABBVIE INC. | $16.84 | 1 |
| Teva Pharmaceuticals USA, Inc. | $15.58 | 1 |
| Acerta Pharma LLC | $15.32 | 1 |
| SANOFI PASTEUR INC. | $14.09 | 1 |
| Abbott Laboratories | $13.96 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $13.96 | 01/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1018956619 | CMS |
| ABBVIE INC. | $16.84 | 01/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997696015 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.32 | 02/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1012054387 | CMS |
| Esperion Therapeutics, Inc. | $15.99 | 01/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050741193 | CMS |
| Esperion Therapeutics, Inc. | $14.58 | 02/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050741195 | CMS |
| Lilly USA, LLC | $14.85 | 01/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031221747 | CMS |
| Lilly USA, LLC | $14.85 | 02/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031223849 | CMS |
| Novo Nordisk Inc | $15.78 | 01/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000753407 | CMS |
| Novo Nordisk Inc | $15.08 | 02/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000753397 | CMS |
| Novo Nordisk Inc | $13.27 | 02/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000753387 | CMS |
| PFIZER INC. | $16.84 | 02/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050537447 | CMS |
| PFIZER INC. | $15.06 | 03/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049322493 | CMS |
| SANOFI PASTEUR INC. | $14.09 | 01/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1044027427 | CMS |
| Teva Pharmaceuticals USA, Inc. | $15.58 | 02/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056899955 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.